News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
260,475 Results
Type
Article (13879)
Company Profile (295)
Press Release (246301)
Section
Business (79326)
Career Advice (150)
Deals (13181)
Drug Delivery (32)
Drug Development (50290)
Employer Resources (31)
FDA (5672)
Job Trends (5114)
News (144071)
Policy (10014)
Tag
Academia (901)
Alliances (21472)
Alzheimer's disease (740)
Approvals (5647)
Artificial intelligence (64)
Bankruptcy (97)
Best Places to Work (4503)
Biotechnology (242)
Breast cancer (70)
Cancer (718)
Cardiovascular disease (65)
Career advice (131)
CAR-T (58)
Cell therapy (182)
Clinical research (39840)
Collaboration (245)
Compensation (100)
COVID-19 (1002)
C-suite (69)
Cystic fibrosis (66)
Data (807)
Diabetes (73)
Diagnostics (1202)
Earnings (28981)
Events (46918)
Executive appointments (196)
FDA (5969)
Funding (256)
Gene editing (55)
Gene therapy (148)
GLP-1 (301)
Government (1063)
Healthcare (6534)
Infectious disease (1037)
Inflammatory bowel disease (94)
IPO (7183)
Job creations (859)
Job search strategy (126)
Layoffs (184)
Legal (1373)
Lung cancer (111)
Manufacturing (75)
Medical device (2552)
Medtech (2553)
Mergers & acquisitions (6107)
Metabolic disorders (226)
Neuroscience (953)
NextGen Class of 2024 (1998)
Non-profit (844)
Northern California (964)
Obesity (125)
Opinion (91)
Parkinson's disease (62)
Patents (54)
People (24995)
Pharmaceutical (50)
Phase I (14019)
Phase II (18532)
Phase III (11744)
Pipeline (327)
Postmarket research (846)
Preclinical (5935)
Radiopharmaceuticals (205)
Rare diseases (172)
Real estate (1409)
Regulatory (8209)
Research institute (930)
Southern California (876)
Startups (1964)
United States (7762)
Vaccines (160)
Weight loss (76)
Date
Today (72)
Last 7 days (341)
Last 30 days (2199)
Last 365 days (20800)
2024 (19200)
2023 (22412)
2022 (26823)
2021 (27809)
2020 (23357)
2019 (16224)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (146)
Asia (16844)
Australia (2839)
California (2188)
Canada (727)
China (168)
Colorado (83)
Connecticut (86)
Europe (36264)
Florida (237)
Georgia (63)
Illinois (129)
Indiana (54)
Kansas (55)
Maryland (305)
Massachusetts (1734)
Michigan (48)
Minnesota (95)
New Jersey (553)
New York (625)
North Carolina (403)
Northern California (964)
Ohio (79)
Pennsylvania (434)
South America (207)
Southern California (876)
Texas (242)
Washington State (224)
260,475 Results for "pinetree therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Pinetree Therapeutics Announces Exclusive Option and Global License Agreement for Preclinical EGFR Degrader Candidate with AstraZeneca
July 23, 2024
·
2 min read
Press Releases
Pinetree Therapeutics Closes $17 Million in Series A Funding to Advance AbReptor™ Protein Degradation Platform and Portfolio Programs
July 30, 2024
·
3 min read
Business
Pinetree Therapeutics Announces Two Appointments to Strengthen its Scientific Leadership
Pinetree Therapeutics, Inc. announced the addition of Pamela A. Trail, PhD, to its Scientific Advisory Board as well as the appointment of John Majercak, PhD, as Chief Technology Officer.
May 31, 2023
·
3 min read
Genetown
PineTree Therapeutics Receives a Bits and Bytes Grant from Massachusetts Life Sciences Center
PineTree Therapeutics and Professors Jason Evans and Nurit Haspel at University of Massachusetts Boston have received capital funding this summer from the Massachusetts Life Sciences Center Bits and Bytes program to accelerate the efforts of PineTree Therapeutics’ next generation biotherapeutics development.
September 27, 2022
·
2 min read
Genetown
PineTree Therapeutics, Inc. Secures $23.5 Million of Series A1 Funding to Develop Cutting Edge Platform Technology to Create Therapeutic Assets for Unmet Medical Needs
PineTree Therapeutics, Inc., an emerging leader in pioneering the development of disruptive therapies in Oncology, Immuno-oncology and other diseases, announced that the company has raised $23.5 Million for Series A1 funding.
June 7, 2022
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
NeuroEM Therapeutics(R) Accepted into StartUp Health’s Alzheimer’s Moonshot Community(TM)
September 19, 2024
·
4 min read
Layoffs
Spero Therapeutics to Lay Off 39% of Employees
Following disappointing results for an antibiotic candidate whose development program is now being suspended, Spero Therapeutics is looking to extend its cash runway while it focuses on other assets in its pipeline.
October 30, 2024
·
1 min read
·
Angela Gabriel
Layoffs
Viracta Therapeutics Cuts 42% of Staff as Part of Resource Reprioritization
Following two layoffs in less than three months, Viracta Therapeutics may have around 18 employees left to advance its efforts to bring lead product candidate nana-val to market.
November 7, 2024
·
2 min read
·
Angela Gabriel
Mergers & acquisitions
Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market Opportunity by 2030
Novartis’ up to $1.1 billion acquisition of gene therapy specialist Kate Therapeutics fits with the pharma’s plan to expand its new modality pipeline to ensure long-term business sustainability.
November 21, 2024
·
2 min read
·
Tristan Manalac
1 of 26,048
Next
